Drug Search Results
More Filters [+]

Policresulen

Alternative Names: policresulen
Latest Update: 2017-01-13
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Protease Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Vaginal

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Argentina | Bulgaria | Canada | China | Colombia | Czech | Dominican Republic | Ecuador | Egypt | Germany | Hong Kong | Hungary | India | Indonesia | Jordan | Korea | Lithuania | Malaysia | Mexico | Pakistan | Peru | Philippines | Poland | Portugal | Russia | Saudi Arabia | Slovenia | Taiwan

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Policresulen

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title